Our results from the two independent and diverse cellular models suggested that chemoresistant PCa cells may rely on, or become “addicted to”, the noncanonical EED-EZH2-Stat3-SKP2-ABCB1/survivin signaling to survive and escape standard chemotherapy. The gene discussed is EZH2; the disease is posterior cortical atrophy.